DoxorubicinAntibiotics, AntineoplasticMedication ErrorsMedication AdherenceMedication ReconciliationMedication SystemsMedication Systems, HospitalVincristineAntineoplastic Combined Chemotherapy ProtocolsRazoxaneCyclophosphamideAntineoplastic AgentsTreatment OutcomeDrug Resistance, NeoplasmDrug CarriersLiposomesPrescription DrugsP-GlycoproteinDrug Administration ScheduleSelf MedicationPatient ComplianceDrug TherapyDrug PrescriptionsPolypharmacyPrednisoneDose-Response Relationship, DrugBreast NeoplasmsDrug Resistance, MultiplePsychotropic DrugsCell Line, TumorPolyethylene GlycolsEtoposidePaclitaxelVinblastineCisplatinDrug-Related Side Effects and Adverse ReactionsCombined Modality TherapyAntipsychotic AgentsDaunorubicinNonprescription DrugsTime FactorsDrug UtilizationDrug SynergismLeukemia P388United StatesAntihypertensive AgentsCardiotoxinsHydroxyethylrutosideDrug ResistancePharmacistsClinical Pharmacy Information SystemsDrug Delivery SystemsIfosfamideRetrospective StudiesApoptosisSarcomaTumor Cells, CulturedProspective StudiesPharmaceutical PreparationsAnthracyclinesFollow-Up StudiesBleomycinCell SurvivalDrug InteractionsMethotrexateAntidepressive AgentsDrug Screening Assays, AntitumorInfusions, IntravenousMedical Order Entry SystemsSurvival AnalysisDrug Therapy, Computer-AssistedDrug CostsDisease-Free SurvivalMitoxantroneHeart DiseasesElectronic PrescribingRisk FactorsVerapamilCardiomyopathiesInsurance, Pharmaceutical ServicesHeartAnti-Asthmatic AgentsFluorouracilPharmaceutical ServicesAntineoplastic Agents, PhytogenicPharmacy Service, HospitalOsteosarcomaCross-Sectional StudiesTaxoidsSurvival RateCohort StudiesDrug Therapy, CombinationPhysician's Practice PatternsQuestionnairesDrug MonitoringDNA Topoisomerases, Type IIDrug LabelingInappropriate PrescribingChemotherapy, AdjuvantCommunity Pharmacy Services